NASDAQ:ASND - Ascendis Pharma A/S Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $122.37 -0.52 (-0.42 %) (As of 05/19/2019 04:00 PM ET)Previous Close$122.37Today's Range$121.0375 - $123.2752-Week Range$53.21 - $131.76Volume188,399 shsAverage Volume281,405 shsMarket Capitalization$5.16 billionP/E RatioN/ADividend YieldN/ABeta0.94 ProfileAnalyst RatingsChartEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Ascendis Pharma A/S (NASDAQ:ASND) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.9 Wall Street analysts have issued ratings and price targets for Ascendis Pharma A/S in the last 12 months. Their average twelve-month price target is $135.00, suggesting that the stock has a possible upside of 10.32%. The high price target for ASND is $219.00 and the low price target for ASND is $81.00. There are currently 9 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 3.003.003.002.89Ratings Breakdown: 0 Sell Rating(s)0 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $135.00$135.00$86.25$77.50Price Target Upside: 10.32% upside17.71% upside17.00% upside21.29% upsideAscendis Pharma A/S (NASDAQ:ASND) Consensus Price Target History Ascendis Pharma A/S (NASDAQ:ASND) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails4/8/2019WedbushReiterated RatingBuy$219.00High4/5/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$132.00 ➝ $133.00Low3/29/2019Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$151.00 ➝ $139.00Low3/25/2019Evercore ISIInitiated CoverageOutperform ➝ OutperformHigh3/18/2019Cantor FitzgeraldReiterated RatingBuy$185.00Low3/7/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00 ➝ $145.00Medium1/24/2019Leerink SwannUpgradeMarket Perform ➝ Outperform$73.00 ➝ $90.00Low8/30/2018Wells Fargo & CoBoost Price TargetOutperform$83.00 ➝ $88.00High8/30/2018Stifel NicolausLower Price TargetBuy ➝ Buy$85.00 ➝ $81.00High1/25/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$45.00 ➝ $60.00High1/19/2018HC WainwrightReiterated RatingBuyMedium(Data available from 5/19/2017 forward) This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: What is insider trading? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.